Skip Navigation


BJA Advance Access originally published online on May 28, 2004
British Journal of Anaesthesia 2004 93(2):241-248; doi:10.1093/bja/aeh181
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/2/241    most recent
aeh181v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Roy, J. J.
Right arrow Articles by Varin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roy, J. J.
Right arrow Articles by Varin, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2004

Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic–pharmacodynamic relationship

J. J. Roy and F. Varin*

Faculté de pharmacie, Université de Montréal, 2900 boul. Edouard Montpetit, C.P. 6128, Succursale Centre-ville, Montréal (Québec), H3C 3J7, Canada

* Corresponding author. E-mail: france.varin{at}umontreal.ca

Background. Among the factors influencing the onset of action of neuromuscular blocking agents (NMBA), the potency (EC50) and the rate of equilibration between blood and the effect compartment (ke0) have been highlighted. Although these descriptors are intrinsically influenced by the physicochemical characteristics of the drug, the impact of lipid solubility, molecular weight and protein binding on pharmacokinetic–pharmacodynamic (PK-PD) descriptors has not been established for most NMBA.

Methods. The octanol/phosphate buffer distribution coefficients (logD) of various NMBA (vecuronium, rocuronium, mivacurium isomers (cis-cis, cis-trans and trans-trans), doxacurium, cisatracurium, atracurium, succinylcholine) were determined. The free fraction for each drug was measured using an ultrafiltration technique. PK-PD descriptors were obtained from selected clinical studies. Correlations between physicochemical parameters (including molecular weight) and PK-PD descriptors were assessed by linear or multiple linear regression.

Results. A wide range of log D (–4.15 for succinylcholine to 0.75 for vecuronium) and free fraction (from 31% for vecuronium to 80% for succinylcholine) is observed for NMBA. Molecular weight combined with either lipid solubility (r2=0.70; P=0.001) or free fraction (r2=0.84; P<0.001) were highly correlated with potency, while for ke0 a greater degree of correlation was obtained when both lipid solubility and free fraction (r2=0.74; P=0.002) were included.

Conclusions. The basic characteristics of NMBAs, namely, molecular weight, lipid solubility and protein binding, are strongly associated with the kinetics of the drug response.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. Liu and J. P. Dilger
Synergy Between Pairs of Competitive Antagonists at Adult Human Muscle Acetylcholine Receptors
Anesth. Analg., August 1, 2008; 107(2): 525 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. Dulvadestin, A. Gilton, P. Hernigou, and J. Marty
The Onset Time of Atracurium Is Prolonged in Patients with Sickle Cell Disease
Anesth. Analg., July 1, 2008; 107(1): 113 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. A. Dahaba, G. Wang, X. Xu, X. Liu, X. Wu, H. Bornemann, and H. Metzler
Influence of acute normovolaemic haemodilution on the dose-response relationship and time course of action of cisatracurium besylate
Br. J. Anaesth., March 1, 2007; 98(3): 342 - 346.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
A. A. Dahaba, S. I. Perelman, D. M. Moskowitz, H. L. Bennett, A. Shander, K. Oettl, G. Reibnegger, and H. Metzler
Influence of acute normovolaemic haemodilution on the dose-response relationship, time-course of action and pharmacokinetics of rocuronium bromide
Br. J. Anaesth., October 1, 2006; 97(4): 482 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
T. Suzuki, G. Masaki, and S. Ogawa
Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients
Br. J. Anaesth., August 1, 2006; 97(2): 160 - 163.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.